According to the DiaFib-Liver Study (2026), liver disease has officially emerged as a ‘fourth major complication’ of Type 2 ...

A major The Lancet study warns liver disease is the “fourth major complication” of diabetes. Analysing 9,000+ patients, ...

Researchers at Toronto's Sinai Health have found that semaglutide—the active ingredient in popular weight loss drugs that ...

Emerging diabetes therapies are transforming MASLD treatment by addressing both metabolic dysfunction and liver disease, with new approvals and a growing pipeline signaling a shift in care. A rapidly ...

Researchers analysed over 9,000 patients using a tool called FibroScan, which measures liver stiffness without needles or ...

A diabetes drug may soon double as a treatment for liver disease. Dapagliflozin, an SGLT-2 inhibitor typically used for type 2 diabetes, significantly improved liver inflammation and scarring in ...

If scientists could shrink themselves to microscopic size and take a journey through the human body—like the submarine crew ...

The forecasting model projects that without major intervention, 1.8 billion people will have MASLD by 2050, and a ...

A new study identifies an easily measured biophysical property that can identify Type 2 diabetics at increased risk for liver cancer who don't meet current screening guidelines. For centuries, doctors ...

Driven by obesity and diabetes, the condition is rising rapidly worldwide, often silently increasing risks of cirrhosis and liver cancer.

Living with diabetes often means carefully managing your condition every day. If you also have a serious form of fatty liver disease called metabolic dysfunction-associated steatohepatitis (MASH), you ...